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A Novel GJB2 (Connexin 26) Mutation, F142L, in a Patient with
Unusual Mucocutaneous Findings and Deafness
To the Editor:
Mutations in GJB2, encoding the gap junction b-2 protein con-
nexin (Cx) 26, cause hearing loss with or without skin disorders.
Mutations in other connexin genes cause hearing loss, skin disor-
ders, peripheral neuropathies, and craniofacial and limb dys-
morphisms (Table I; Kelsell et al, 2001; Rabionet et al, 2002;
Paznekas et al, 2003).
A 2 y old Caucasian female with psoriasiform mucocutaneous
involvement, in£ammation of mucous membranes, and severe to
profound, bilateral, sensorineural hearing loss was ascertained.
Hearing loss was diagnosed by auditory brainstem response test
(ABR) at 13 mo of age after failure to develop speech. Cutaneous
¢ndings include: (1) periori¢cial and truncal erythematous
patches and scaly erythematous plaques that also involve the face,
upper extremities, and diaper area (Fig 1A); (2) exuberant granu-
lation tissue around a gastrostomy and on the perianal skin; (3)
scaling and obstruction of the external auditory canals; (4) scaly
crusted plaques on the scalp; (5) sparse hair that has ¢lled in with
age; and, (6) calcinosis cutis of both heels. There is no palmoplan-
tar hyperkeratosis, nail or hair dysplasia. Skin biopsy reveals
mostly orthokeratotic hyperkeratosis with focal parakeratosis,
acanthosis, and slight papillomatosis of the epidermis, and foci
of acute and chronic in£ammation in the subepidermal layer
and epidermis.
Oral ¢ndings include multiple large dental lamina cysts (Fig 1B)
that resolved spontaneously, and primary teeth with focal enamel
hypoplasia. The oropharyngeal mucosa shows di¡use erythema
with focal ulceration, corrugation, and adherent white plaques
(Fig 1C). Intermittent angular cheilitis is observed. Histopatholo-
gic features of the oral mucosa show hyperparakeratosis, acan-
thosis, and scattered neutrophils in the super¢cial epithelium
adjacent to an ulcer.
Endoscopy of the upper gastrointestinal tract reveals a denuded
and friable esophagus with marked mucosal in£ammation incon-
sistent with Crohn’s disease, and esophageal stricture. The muco-
sal involvement impairs swallowing, resulting in the placement
of a gastrostomy.
Other problems include recurrent urinary tract infections,
perirectal abscesses, otitis externa, otitis media, iron de¢ciency
anemia, and reactive thrombocytosis. At 17 mo of age, a brain
magnetic resonance imaging showed a mild delay in myelination.
Table I. Connexins in deafness, skin disease,
and other disorders
Protein Gene symbol Phenotypes
Cx26 GJB2 Nonsyndromic hearing loss
Keratitis-ichthyosis-deafness syndrome
Hystrix-like ichthyosis-deafness syndrome
Vohwinkel syndrome (mutilating keratoderma
and hearing impairment)
Di¡use palmoplantar keratoderma and deafness
Cx30 GJB6 Nonsyndromic hearing loss
Clouston syndrome (hidrotic ectodermal dysplasia)
Cx30.3 GJB4 Erythrokeratodermia variabilis
Cx31 GJB3 Nonsyndromic hearing loss
Erythrokeratodermia variabilis
Peripheral neuropathy and hearing loss
Cx32 GJB1 Charcot-Marie-Tooth disease with or without
hearing loss
Cx43 GJA1 Nonsyndromic hearing loss
Oculodentodigital dysplasia
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Laboratory studies exclude autoimmune blistering disorders,
overt zinc de¢ciency, and immune de¢ciencies (including assess-
ment of humoral, cellular, phagocytic, chemotactic and comple-
ment functions). Fungal culture and silver staining exclude
mucocutaneous candidiasis. Family history is negative for consan-
guinity, hearing loss, and similar skin disease. Chromosome
analysis reveals a 46,XX female karyotype.
The cutaneous lesions have improved signi¢cantly, but the
severe mucositis persists. The patient received a MED-EL Combi
40þ cochlear implant device (MED-EL, Innsbruck, Austria)
through minimal incision surgery. She is 1 y postimplant, and
speech and language milestones are age appropriate.
The combination of prelingual hearing loss, a congenital dis-
order of corni¢cation, and involvement of ectodermal tissues
prompted screening of the GJB2 gene, revealing a heterozygous
424T4C mutation predicted to replace the phenylalanine at po-
sition 142 of Cx26 with a leucine (F142L) (Fig 2). This mutation
is not present in either parent. Paternity was con¢rmed by geno-
type analysis of 13 informative short tandem repeats (STRs)
from di¡erent chromosomes, yielding a probability of paternity
of 0.999999944, assuming a prior probability of 0.50. These ¢nd-
ings indicate that mutation 424T4C has arisen de novo, similar
to most GJB2 mutations in keratitis^ichthyosis^deafness and
hystrix-like ichthyosis^deafness syndromes (Richard et al, 2002;
van Geel et al, 2002; van Steensel et al, 2002).
The 424T4C mutation was not found in 214 control chromo-
somes of una¡ected individuals of northern and middle European
descent, or in 77 Egyptian individuals, nor was it reported by
other groups screening thousands of GJB2 sequences worldwide
(Kenneson et al, 2002; Calvo et al, 2003), excluding a common
sequence polymorphism.
The complex phenotype and heterozygous state of the
424T4C GJB2 mutation prompted investigation of additional
epidermal and cochlear connexins for sequence variations that
might modify the phenotypic expression of GJB2 F142L. Se-
quence analysis of the coding regions of GJB6, GJB4, and GJA1
did not reveal sequence aberrations. GJB6 was also negative for a
342 kb deletion known to cause hearing loss (Lerer et al, 2001). In
the coding sequence of GJB3, a heterozygous silent mutation
(S88S) that is most likely inconsequential for protein function
was found.
A history of repeated exposure to aminoglycoside antibiotics
prompted analysis of the mitochondrial 12S rRNA gene. Neither
the A1555G nor the 961delTþC(n) mutation (Casano et al, 1999)
was detected.
The amino acid sequence of human Cx26 was aligned with
human, mouse, and rat Cx26, Cx30, Cx30.3, Cx31, Cx31.1, and
Cx32, human Cx43, and with Cx26 from gibbon, gorilla, oran-
gutan, dog, Rhesus monkey, sheep, and cow. The phenylalanine
Figure1. Clinical and histologic ¢ndings. (A) Psoriasiform dermatitis
occurring as scaly erythematous plaques on the trunk and diaper area. (B)
Gingiva, showing multiple large dental lamina cysts. (C) Generalized
erythema of the oral mucosa with focal ulceration and adherent white
plaques.
Figure 2. DNA sequence analysis of GJB2.The heterozygous 424T4C
transition is indicated by the arrow. The nucleotide sequence is provided,
just above the electropherograph. The amino acid sequence, indicating the
heterozygous amino acid substitution (F/L), is shown above the nucleotide
sequence. Position F142 is noted.
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at position 142 of Cx26 is invariably present and evolutionarily
conserved.
The phenylalanine at position 142 is located in the third trans-
membrane domain of Cx26. Similar mis-sense mutations a¡ect-
ing orthologous residues in other connexin genes have been
reported in erythrokeratodermia variabilis (F137L in GJB3 and
GJB4) and X-linked Charcot^Marie^Tooth disease (F141L in
GJB1) (Rouger et al, 1997; Richard et al, 1998b, 2000; Macari et al,
2000).
The importance of the third transmembrane domain in forma-
tion of the gap junction pore wall and the voltage gating and clo-
sure of gap junction channels has been shown (Unwin, 1989;
Bennett et al, 1991; Hennemann et al, 1992; Macari et al, 2000).
The channel kinetics of connexins with a di¡erent number of
phenylalanine residues in the third transmembrane domain dif-
fers: the more phenylalanines present, the slower the channel
closes; the fewer phenylalanines present, the faster the channel
closes (Unwin, 1989; Hennemann et al, 1992; Macari et al, 2000).
Macari et al (2000) suggested that loss of the orthologous pheny-
lalanine residue in the third transmembrane domain of Cx30.3
might result in faster closure of gap junction channels and inhi-
bition of signal propagation. Similarly, it is possible that the
phenotype in the patient described herein might be due to dysre-
gulation of channel closure, caused by loss of the phenylalanine at
position 142.
Moreover, this mutation could interfere with the a-helical
structure of the transmembrane domain or the proper topogenic
assembly of connexin hemichannels. Dominant mutations in
Cx26 (Richard et al, 1998a; White et al, 1998; Rouan et al, 2001;
Marziano et al, 2003) and Cx50 (Pal et al, 1999) have been shown
in vitro to exert a dominant negative e¡ect on wild-type proteins.
The F142L mutation in Cx26 may also exert a dominant negative
e¡ect on wild-type Cx26, and potentially also on the function of
selected other connexin species (Rouan et al, 2001; Marziano et al,
2003).
In summary, a novel GJB2 mis-sense mutation, F142L, was
detected in a patient without the classic features of Vohwinkel,
keratitis^ichthyosis^deafness, or hystrix-like ichthyosis^deafness
syndromes. These data suggest that dominant GJB2 mutations
are associated with diverse clinical phenotypes. Functional ana-
lyses and characterization of other individuals carrying this
mutation are necessary to establish the pathogenic role of this
mutation.
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